奥希替尼和血管内皮生长因子受体抑制剂联合治疗表皮生长因子受体突变的非小细胞肺癌：旧方案还是新方案？

{"title":"奥希替尼和血管内皮生长因子受体抑制剂联合治疗表皮生长因子受体突变的非小细胞肺癌：旧方案还是新方案？","authors":"Hirotsugu Kenmotsu","doi":"10.1200/JCO-24-01921","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":" ","pages":"369-372"},"PeriodicalIF":42.1000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Combination of Osimertinib and Vascular Endothelial Growth Factor Receptor Inhibitors for <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: Old or New Regimen?\",\"authors\":\"Hirotsugu Kenmotsu\",\"doi\":\"10.1200/JCO-24-01921\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":15384,\"journal\":{\"name\":\"Journal of Clinical Oncology\",\"volume\":\" \",\"pages\":\"369-372\"},\"PeriodicalIF\":42.1000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1200/JCO-24-01921\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/11 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/JCO-24-01921","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}